CORPUS CHRISTI, Texas (AP) — The compounding pharmacy linked to 17 bacterial infections at two Corpus Christi hospitals says it has found no evidence of contamination in its building or products.
The federal Food and Drug Administration recalled all products produced by Specialty Compounding of Cedar Park after reports of bacterial infections affecting the 17 patients.
Two patients died. But Texas health officials said previously they'd found no link between the recalled medication and the deaths of those who took it before the recall.
The Corpus Christi Caller Times reported (http://bit.ly/1fMH2BW ) Sunday that a representative for Specialty Compounding said the company hired a microbiologist to do its own inspection of the facility and to test samples — including swabbing the noses of pharmacists and technicians working there.
It found no evidence of the bacterium, Rhodococcus equi, found in the blood of 17 people who fell ill at Corpus Christi Medical Center hospitals, Doctors Regional and Bay Area, said David Ball, a spokesman hired by the pharmacy.
"There are literally hundreds of potential sources of contamination," Ball told the newspaper. "There's no evidence at this time that the contamination is connected to Specialty Compounding."
continue to read here
No comments:
Post a Comment